Global Nasal Drug Delivery Technology Market Segmentation, By Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels and Ointments, Nasal Powders, Others), Container Type (Non-Pressurized Containers, Pressurized Containers), System Type (Multi-Dose, Bi-Dose, Unit Dose), Therapeutic Application (Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Home Care) - Industry Trends and Forecast to 2031.
Nasal Drug Delivery Technology Market Analysis
Nasal medication delivery has become one of the most studied topics in recent years. Companies have used new technologies to create tiny, portable, and user-friendly products. Because it gives a speedier beginning of action for the treatment of associated disorders, the nasal route has been regarded as acceptable for medication delivery. As more patients are diagnosed with restrictive respiratory conditions such as asthma and chronic obstructive pulmonary disease, and overall health care remains pricey, people are predicted to gravitate toward more generic products.
Nasal Drug Delivery Technology Market Size
Global nasal drug delivery technology market size was valued at USD 73.50 billion in 2023 and is projected to reach USD 126.29 billion by 2031, with a CAGR of 7.00% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Nasal Drug Delivery Technology Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Merck & Co., Inc. (US), GlaxoSmithKline plc (UK), AstraZeneca (UK), Johnson & Johnson Private Limited (India), Mystic Pharmaceuticals (US), Bausch Health Companies Inc. (Canada), BD (US), 3M (US), AptarGroup, Inc. (US), OptiNose US, Inc. (US), Dr. Reddy’s Laboratories Ltd (India), Flo Nasal Products. (Australia), Cadila Pharmaceuticals (India), PendoPharm Inc. (Canada), Neurelis, Inc. (US).
|
Nasal Drug Delivery Technology Market Definition
Nasal medication delivery is the process of delivering pharmaceuticals or drugs through the nasal passage. The technology's main advantages are its high effectiveness and efficiency in treating the target illnesses. Because it comprises a relatively streamlined and methodical technique of drug distribution, this mode of drug delivery is known to be a direct alternative to invasive modalities.
Nasal Drug Delivery Technology Market Dynamics
Drivers
Major factors that are expected to boost the growth of the nasal drug delivery technology market in the forecast period are as follows:
- Rise in the patient preference for nasal drug delivery
One of the most popular drug delivery routes among patients and healthcare providers is intranasal drug delivery. This is due to the non-invasive nature of this mode of delivery and the fact that medication absorbability is higher via the nasal route.
- Increasing adoption of self-administration practices
Unlike some other methods of drug delivery, nasal drug delivery does not necessitate the use of a sterile method for introducing medications into the body. The ease with which these pharmaceuticals are administered is critical in enhancing patient adherence to drug regimens, which leads to better patient outcomes.
- Introduction of Off-patent Drugs for Respiratory Care
The development of generic inhalation drugs is being driven by the patent expiration of branded inhaled pharmaceuticals and increasing pressure on the healthcare budget. As the cost of treating asthma and COPD decreases, patients are more likely to become aware of DPIs and MDIs and use them.
Opportunities
In addition, the easy availability of nasal drugs and growing attention on alternative routes such as nasal drug delivery are further provide potential opportunities for the growth of the nasal drug delivery technology market in the coming years.
Restraints/Challenges
On the other hand, the difficulties regarding the overuse of nasal sprays is further projected to impede the growth of the nasal drug delivery technology market in the targeted period. However, the regulatory hurdles might further challenge the growth of the nasal drug delivery technology market in the near future.
This nasal drug delivery technology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nasal drug delivery technology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Nasal Drug Delivery Technology Market
The COVID-19 pandemic had a beneficial impact on the nasal drug delivery industry since many patients wanted to do their chronic respiratory disease drug therapy at home, resulting in an increase in the use of inhalers at home rather than in hospitals or outpatient clinics. There was also an increase in the use of nasal inhalers to treat asthma, migraines, and other mental illnesses. Moreover, several pharmaceutical companies have delved into the production of vaccines using nasal drug delivery technology, with a number of them currently in clinical testing.
Nasal Drug Delivery Technology Market Scope
The nasal drug delivery technology market is segmented on the basis of dosage form, container type, system type, therapeutic application, distribution channel and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Dosage Form
- Nasal Spray
- Nasal Drops
- Nasal Gels and Ointments
- Nasal Powders
- Others
Container Type
- Non-Pressurized Containers
- Pressurized Containers
System Type
- Multi-Dose
- Bi-Dose
- Unit Dose
Therapeutic Application
- Allergic and Non-Allergic Rhinitis
- Nasal Congestion
- Asthma
- Vaccination
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
End User
- Hospitals
- Home Care
Nasal Drug Delivery Technology Market Regional Analysis
The nasal drug delivery technology market is analysed and market size insights and trends are provided by country, dosage form, container type, system type, therapeutic application, distribution channel and end user as referenced above.
The countries covered in the nasal drug delivery technology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the nasal drug delivery technology market due to the rise in disease incidence. Furthermore, the growing consumer awareness about nasal products will further boost the growth of the nasal drug delivery technology market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the nasal drug delivery technology market due to the accessibility of efficient treatment methods and growing disposable income levels. Moreover, the increased unmet clinical demands and growing awareness about these products is further anticipated propel the growth of the nasal drug delivery technology market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Nasal Drug Delivery Technology Market Share
The nasal drug delivery technology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nasal drug delivery technology market.
Nasal Drug Delivery Technology Market Leaders Operating in the Market Are:
- Merck & Co., Inc. (US)
- GlaxoSmithKline plc (UK)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (India)
- Mystic Pharmaceuticals (US)
- Bausch Health Companies Inc. (Canada)
- BD (US)
- 3M (US)
- AptarGroup, Inc. (US)
- OptiNose US, Inc. (US)
- Dr. Reddy’s Laboratories Ltd (India)
- Flo Nasal Products. (Australia)
- Cadila Pharmaceuticals (India)
- PendoPharm Inc. (Canada)
- Neurelis, Inc. (US)
Latest Developments in Nasal Drug Delivery Technology Market
- In March 2021, Aptar Pharma and Noble, a subsidiary of Aptar Pharma, have established a partnership with dne pharma, a leader in addiction medicine in Northern Europe. The firms supply nasal drug delivery proficiency and training solutions for dne pharma's Ventizolve nasal naloxone to treat opioid overdose.
- In February 2021, by establishing a non-exclusive agreement for formulation proof of concept projects, Nanoform Finland and Herantis announced their collaboration on nasal medicine delivery to the brain.
SKU-